Navigation Links
RxTrials Earns National Women-Owned Business Certification
Date:1/25/2011

ELLICOTT CITY, Md., Jan. 25, 2011 /PRNewswire/ -- RxTrials, Inc., a network of premier clinical research sites and parent company of RxTrials Institute, a leading national clinical research consultant and education provider, has earned status as a Women Business Enterprise (WBE). The WBE certification was presented by the Women's Business Enterprise National Council (WBENC) following a rigorous review process and site visit.

The nationally recognized certification from WBENC helps to maximize opportunities for women owned business to participate in contracting and purchasing activities. WBENC certification tells partnering companies that the business meets a set of national standards and adheres to strong business ethics.

Certification from WBENC often is sought by companies that are leaders in their industries and whose owners wish to demonstrate their commitment to growth and progress for companies that are owned and managed by women.

"Obtaining certification from WBENC was a personal goal of mine for RxTrials to be a voice and encouragement for other women and specifically young women to aspire to realize their dreams," said Christine Pierre, President. "As RxTrials approaches its 16th year in business, it is quite meaningful that we have achieved this goal and have a recognized voice in our industry."

More information about WBENC certification is available online at www.wbenc.org.

About RxTrials, Inc.

RxTrials is a network of premier Investigative Sites that conduct Phase II through Phase IV and vaccine clinical research studies, based in physician practices, clinics and hospitals. Since 1994, RxTrials has successfully completed more than 1,000 studies and is a strategic partner with leading Sponsors and CROs. Through its sister company, RxTrials Institute, RxTrials provides professional training, education and consultation, and sponsors the annual Site Solutions Summit. More information can be found at www.rxtrialsinc.com.


'/>"/>
SOURCE RxTrials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Singapore consortium learns from nature to produce new chemical-free, anti-bacteria plastic skins
2. Rigel Earns Milestone Payments From AstraZeneca
3. Livermores DTEM earns innovation award from Microscopy Today
4. Isis Earns $5 Million Milestone Payment From GSK for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease
5. Wake Forest earns patent for efficient, inexpensive fiber-based solar cells
6. Michael Sitaras of SavATree Earns ISA Certified Arborist Designation
7. iCorps Technologies Earns CompTIA Security Trustmark™
8. BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification
9. Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
10. Professor-turned-producer learns the movie biz
11. Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Charlotte, N.C. (PRWEB) , ... October 11, 2017 ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the ... Laboratories ( ASTER Labs ), Inc. has been selected for membership in ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):